XML 45 R33.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Revenue Recognition (Tables)
3 Months Ended
Mar. 31, 2024
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue
The following table represents Evolent’s revenue disaggregated by end-market and product type (in thousands):
For the Three Months Ended
March 31,
20242023
Medicaid$215,124 $183,034 
Medicare286,960 127,669 
Commercial and other137,569 116,987 
Total$639,653 $427,690 
Performance Suite$448,218 $239,873 
Specialty Technology and Services Suite89,003 65,316 
Administrative Services58,569 83,067 
Cases43,863 39,434 
Total$639,653 $427,690 
Schedule of Contract with Customer, Asset and Liability
The following table provides information about receivables, contract assets and deferred revenue from contracts with customers as of March 31, 2024 and December 31, 2023 (in thousands):
March 31, 2024December 31, 2023
Short-term receivables (1)
$426,561 $446,220 
Short-term deferred revenue6,136 5,976 
Long-term deferred revenue879 1,173 
————————
(1)Excludes pharmacy rebate receivable and pharmacy claims receivable.

Changes in deferred revenue for the three months ended March 31, 2024 are as follows (in thousands):
Deferred revenue
Balance as of beginning-of-period$7,149 
Reclassification to revenue, as a result of performance obligations satisfied(3,277)
Cash received in advance of satisfaction of performance obligations3,143 
Balance as of end of period$7,015